Evidence map›Paper›PMID 24699535›Full record

ArticlePloS one2014

Leukocyte attraction by CCL20 and its receptor CCR6 in humans and mice with pneumococcal meningitis.

Matthias Klein, Matthijs C Brouwer, Barbara Angele, Madelijn Geldhoff, Gabriel Marquez, Rosa Varona, Georg Häcker, Helga Schmetzer, Hans Häcker, Sven Hammerschmidt and 4 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Actin Cross-Linking Effector Domain of theInfection and immunity · 2022
    Article
  14. Assessment of changes in genetic transcriptome in nasal epithelial cells exposed to ozone-aged black carbon and pollen allergen by high-throughput transcriptomics.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2021
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 4 countries.

Matthias KleinDepartment of Neurology, Ludwig-Maximilians-University, Munich, Germany.
Matthijs C BrouwerDepartment of Neurology, University of Amsterdam, Amsterdam, The Netherlands; Center of Infection and Immunity Amsterdam, Academic Medical Center, Amsterdam, The Netherlands.
Barbara AngeleDepartment of Neurology, Ludwig-Maximilians-University, Munich, Germany.
Madelijn GeldhoffDepartment of Neurology, University of Amsterdam, Amsterdam, The Netherlands; Center of Infection and Immunity Amsterdam, Academic Medical Center, Amsterdam, The Netherlands.
Gabriel MarquezGenetrix, Madrid, Spain.
Rosa VaronaDepartamento de Immunologia y Oncologia, Centro National de Biotecnologia, Madrid, Spain.
Georg HäckerInstitute for Medical Microbiology and Hygiene, Albert-Ludwigs-University Freiburg, Freiburg, Germany.
Helga SchmetzerMedical Department III, Ludwig-Maximilians-University, Munich, Germany.
Hans HäckerDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Sven HammerschmidtDepartment Genetics of Microorganisms, University of Greifswald, Greifswald, Germany.
Arie van der EndeCenter of Infection and Immunity Amsterdam, Academic Medical Center, Amsterdam, The Netherlands; Department of Medical Microbiology, University of Amsterdam, Amsterdam, The Netherlands.
Hans-Walter PfisterDepartment of Neurology, Ludwig-Maximilians-University, Munich, Germany.
Diederik van de BeekDepartment of Neurology, University of Amsterdam, Amsterdam, The Netherlands; Center of Infection and Immunity Amsterdam, Academic Medical Center, Amsterdam, The Netherlands.
Uwe KoedelDepartment of Neurology, Ludwig-Maximilians-University, Munich, Germany.
Ludwig-Maximilians-Universität München · DEAcademic Medical Center · NLUniversity of Amsterdam · NLCentro Nacional de Biotecnología · ESGenetrix (Spain) · ESInstitute of Medical Microbiology and Hygiene · DESt. Jude Children's Research Hospital · USUniversität Greifswald · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously identified CCL20 as an early chemokine in the cerebrospinal fluid (CSF) of patients with pneumococcal meningitis but its functional relevance was unknown. Here we studied the role of CCL20 and its receptor CCR6 in pneumococcal meningitis. In a prospective nationwide study, CCL20 levels were significantly elevated in the CSF of patients with pneumococcal meningitis and correlated with CSF leukocyte counts. CCR6-deficient mice with pneumococcal meningitis and WT mice with pneumococcal meningitis treated with anti-CCL20 antibodies both had reduced CSF white blood cell counts. The reduction in CSF pleocytosis was also accompanied by an increase in brain bacterial titers. Additional in vitro experiments showed direct chemoattractant activity of CCL20 for granulocytes. In summary, our results identify the CCL20-CCR6 axis as an essential component of the innate immune defense against pneumococcal meningitis, controlling granulocyte recruitment.

Indexed as

AdultAgedAnimalsAntibodies, MonoclonalBlotting, WesternBrainCase-Control StudiesCells, CulturedChemokine CCL20Chemotaxis, LeukocyteEnzyme-Linked Immunosorbent AssayFemaleFlow CytometryHumansImmunoenzyme TechniquesMaleAntibodies, MonoclonalChemokine CCL20Receptors, CCR6

Identifiers

PMID24699535
PMCPMC3974727
OpenAlexW2000872236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.